MedCity News June 3, 2025
This is the moment to build flexible plans. Organizations that develop operational models with built-in scenario planning, ready to scale up or down as the capital environment shifts, will be positioned to take advantage of greater investment when it comes.
The clinical trial industry is navigating a period of regulatory uncertainty, geopolitical tension, and potential targeted tariffs. This climate of economic uncertainty is forcing sponsors to reassess their pipelines and scrutinize the efficiency of their R&D investments, while emerging biotechs face a tougher funding environment.
While tariffs and macroeconomic pressures dominate headlines, they’re only part of the story. The broader reality is that trial starts dropped for several quarters before stabilizing again more recently. This change feels structural as much...
Today's Sponsors
Today's Sponsor